Reward Deficiency Syndrome Solution Focused Brief Therapy (RDS-SFBT), provided in both individual and group therapy formats, in the practice of Addiction Recovery Treatment, will help the client understand the importance of the challenge to achieve dopamine homeostasis in the recovery process. RDS-SFBT introduces new Reward Deficiency Syndrome concepts and solutions to the practitioner-client world, helping to bridge the gap between the worlds of research and therapeutic practice [1]. Newly created RDS-SFBT will bring awareness of the advancements of cutting-edge global Reward Deficiency Syndrome research efforts [2], and expands the resource application available to the consumer.

A gap between public understanding, cutting edge brain science and the practice of addiction treatment has created hardship for those suffering. New perspective replaces the term addiction with the new concept of a continuum of substance use. Substance Use Disorder (SUD) is now regarded as a manifestation of Reward Deficiency Syndrome, which contributes to a spectrum of disorders related to genetic polymorphisms, especially in regard to impulsive, addictive and compulsive behaviors. The new brain science of addiction requires neurological medical intervention and novel treatment with nutraceuticals, the building blocks of neurotransmission. Innovative alterative holistic and wellness therapies are proving to be beneficial in helping the sufferer thrive despite chronic neurological challenge.

The evolving science of Attention Deficit Hyperactivity Disorder garners insight from many sciences for enlarged perspective, expanding theoretical understanding, and broadening treatment applications. Comorbidity and ADHD's shared characteristics with other disorders have made diagnosis difficult, especially when professional trends base diagnosis upon a cluster of symptoms. Neuroscience is now pinpointing energetic signatures of the disease's electromagnetic expression. In addition to traditional pharmacological and behavioral therapeutic treatments, neuro-therapy is being prescribed in the form of neurofeedback.The amount of research on the global spectrum is extremely vast, far reaching, crossing over the limitations of former boundaries, and expanding exponentially. It is a daunting task for those in the practice of medicine to keep abreast of the latest research in the field of one's own specialty, much less to be informed of the advancements in inter-related or cross over fields. Typically, research science is thirty to fifty years ahead to what is available to the public. For example, based upon the past fifty years of research, a new disease has come to the forefront of the research arena, Reward Deficiency Syndrome (RDS). Addiction is one of its behavioral expressions. This is huge.Addiction is no longer viewed as the disease. It is the symptom. ADHD is closely associated with RDS and is viewed as a precursor to addiction. On the post doctoral level of research science, for those in the know, there is no debate. However, unfortunately, many in the practice of medicine are uninformed, and still using last century's ADHD and addiction conceptual criteria.

No abstract

This is the third article in a series of three looking at the implementation of the regular use of sessional and outcome measures using CORE-Net within the training of clinical psychologists. A trainee from each university involved in the project (Hull, Sheffield and Leeds) was asked to give their reflections on this process.